Clinical Trial Update: Effect of Methylphenidate on Connectivity [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating methylphenidate on brain connectivity in attention-deficit/hyperactivity disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Iris Sommer | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: WITHDRAWN